Inter-laboratory comparison of chronic myeloid leukemia minimal residual disease monitoring: summary and recommendations.
about
Interpreting molecular monitoring results and international standardization in chronic myeloid leukemia.Guide to interpreting disease responses in chronic myeloid leukemia.Understanding the economic value of molecular diagnostic tests: case studies and lessons learned.Rapid initial decline in BCR-ABL1 is associated with superior responses to second-line nilotinib in patients with chronic-phase chronic myeloid leukemiaA certified plasmid reference material for the standardisation of BCR-ABL1 mRNA quantification by real-time quantitative PCRQuality control methods for optimal BCR-ABL1 clinical testing in human whole blood samplesValidation of a rapid one-step high sensitivity real-time quantitative PCR system for detecting major BCR-ABL1 mRNA on an International Scale.LightCycler technology in molecular diagnostics.Harmonization of molecular monitoring of CML therapy in Europe.Molecular techniques for the personalised management of patients with chronic myeloid leukaemia.Personalised treatment of haematological malignancies through systems medicine based on single molecules in single cells.Diagnosis and Treatment of Chronic Myeloid Leukemia in 2015.dPCR: A Technology Review.Measurement of BCR-ABL1 transcripts on the International Scale in the United States: current status and best practices.Harmonization of molecular monitoring of chronic myeloid leukemia therapy in Japan.
P2860
Q33885583-53A3D438-AA64-4B11-B62B-A3E7864AF42BQ33885637-262FD789-215F-44EF-BC27-B626F5A9089BQ34608705-8A4A9B14-56D9-48B3-BA52-42677055F17DQ34644820-69EC025B-C1D6-4CF2-B22F-B507FE0013D0Q35059443-E7C5D74A-B9DE-44E8-B22B-0BA912816BA4Q36817650-DB065D5A-103C-448B-A4AD-35E133A17A2CQ36894983-BAB93980-07DD-47F8-91DF-AFEBBD3B9557Q37386543-521C0FC2-A1EB-4088-94D1-DAC389D165B7Q37587749-5429D614-B873-464B-9990-AB7758633F99Q37696776-CCC113E1-E5BC-4FC9-9F29-F42962705E03Q38093422-B14FAC78-C1B0-4B2B-80D6-E215256ABD9FQ38598820-89CCE4E3-C9CB-49C6-A3A9-808F1719C7CCQ52574457-CA06225A-D81A-4DB3-AFF4-AA357A43B741Q52992928-610C66E2-7544-4A1E-AAD8-6C73D7F39A63Q53089883-41557994-12F2-4995-9C15-832D7FC0DB4E
P2860
Inter-laboratory comparison of chronic myeloid leukemia minimal residual disease monitoring: summary and recommendations.
description
2007 nî lūn-bûn
@nan
2007年の論文
@ja
2007年論文
@yue
2007年論文
@zh-hant
2007年論文
@zh-hk
2007年論文
@zh-mo
2007年論文
@zh-tw
2007年论文
@wuu
2007年论文
@zh
2007年论文
@zh-cn
name
Inter-laboratory comparison of ...... : summary and recommendations.
@en
type
label
Inter-laboratory comparison of ...... : summary and recommendations.
@en
prefLabel
Inter-laboratory comparison of ...... : summary and recommendations.
@en
P2093
P2860
P1476
Inter-laboratory comparison of ...... : summary and recommendations.
@en
P2093
Association for Molecular Pathology Hematopathology Subdivision
Bevoline Nwachukwu
Cuihong Wei
Jeffrey H Lipton
Sylvie Grenier
Tong Zhang
P2860
P304
P356
10.2353/JMOLDX.2007.060134
P577
2007-08-09T00:00:00Z